United States:
Prescription Drug Purchasing Initiative In California Raises Legal Questions
24 January 2019
Reed Smith
To print this article, all you need is to be registered or login on Mondaq.com.
Last week, California Governor Gavin Newsom signed an Executive
Order creating a program to lower prescription drug costs
throughout the state. This initiative could significantly impact
pharmaceutical manufacturers, managed care companies, pharmacies
and other industry participants, as well as prescription drug
consumers. Reed Smith's health care and antitrust teams
summarize Newsom's Executive Order and address consequent legal
and policy issues in this
client alert.
This article is presented for informational purposes only
and is not intended to constitute legal advice.
POPULAR ARTICLES ON: Antitrust/Competition Law from United States
US Antitrust Agencies Release Final Revised Merger Guidelines
Goodwin Procter LLP
On December 18, 2023, the Federal Trade Commission and the Antitrust Division of the Department of Justice released the final version of revised Merger Guidelines, a set of principles Agencies use in their review of mergers and acquisitions.
NCAA Updates Guidance On Transfer Rules
McLane Middleton, Professional Association
In December 2023, the State of Ohio sued the NCAA in the United States District Court for the District of West Virginia, challenging the organization's transfer waiver policy...